Long path back to business as usual, UK’s coronavirus genome expert says
It is a long road back to business as usual from the COVID-19 pandemic, the head of Britain’s coronavirus genome sequencing effort told Reuters, adding she was on alert for new mutations to the Delta variant that is sweeping the world.
Prime Minister Boris Johnson has ended England’s coronavirus lockdown, saying Britain must cautiously learn to live with the virus, and that a quick vaccine rollout has allowed for a summer reopening.
Read the latest updates in our dedicated coronavirus section.
Sharon Peacock, chair of the COVID-19 Genomics UK (COG-UK) consortium, said that the process of returning to normal would be slow, due to uneven vaccine rollouts globally.
For the latest headlines, follow our Google News channel online or via the app.
“It’s quite a long path to get back to business as usual,” she told Reuters, adding that clear global surveillance for new variants and co-ordination on the best vaccine against what is coming up, as there is with flu, would be needed.
“I see that as quite a long journey. So it’s not going to be one day that we wake up and say right we’re going to live with COVID-19 and everything’s okay. I think there’s still a lot of groundwork to be done.”
Britain has launched a New Variant Assessment Platform Program to share its genomics expertise globally.
The variant of biggest concern at the moment is the Delta variant, which Peacock characterizes as the “fittest and fastest variant yet”.
Delta is highly transmissible and has also been shown to reduce the effectiveness of the first dose of COVID-19 vaccines, and could become even more troublesome.
“There’s quite a lot of new mutations in the Delta variant, and so that’s being watched very carefully. There’s no reason at this point in time to be alarmed about that,” she said.
“But we have to continue to watch for a particular sort of variant of a variant if you like, that is associated with, for example, even more spread... That’s under constant monitoring at the moment.”
Read more: How the Delta variant upends researchers' assumptions about COVID-19
-
How the Delta variant upends researchers' assumptions about COVID-19
The Delta variant is the fastest, fittest and most formidable version of the coronavirus that causes COVID-19 the world has encountered, and it is ... Coronavirus -
India to miss end-July vaccination target as Bharat Biotech lags in ramping up output
India will miss a target to administer over a half billion COVID-19 vaccine doses by the end of the month as Bharat Biotech -- maker of its only ... Coronavirus -
Antibodies decline in six months after taking Sinovac shot, booster helps: Study
Antibodies triggered by Sinovac Biotech’s COVID-19 vaccine decline below a key threshold from around six months after a second dose for most ... Coronavirus -
Vaccine maker BioNTech to use mRNA tech behind its COVID-19 vaccine to target malaria
Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.The ... Healthy Living